InvestorsHub Logo
icon url

borntwice

12/10/09 12:17 PM

#6550 RE: mr_sano #6547

Why is it so hard to produce an image? And they didn't bring 'good' images to RSNA? What's that all about? Can someone explain why they brought bad images to RSNA? TIA
icon url

AOK11

12/10/09 12:18 PM

#6551 RE: mr_sano #6547

Not adding additional marketing material that could jeopardize, or at very least extend, the review of product labeling makes perfect sense actually. What the FDA has to consider now is the totality of advertising, marketing, etc.. to see if there is something that doesn't gel with the proposed use. I personally think it's smart not to muddy the review waters now with new images.

Besides, there's just one or two days left before we should get a response. Is it really that urgent?
icon url

lennygoat

12/10/09 12:24 PM

#6553 RE: mr_sano #6547

why are you so driven to see the latest images? if you don't think it works by this point, you shouldn't be invested in this stock. Dean's logic about why he doesn't want to release the images seems to be centered on not disrupting the FDA process. are you implying it's more important to satisfy investors hunger for more images than to get the product thru FDA approval??